Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederclinicaltrials.gov
ClinicalTrials.gov: Tirzepatide OR Mounjaro OR LY3298176 OR Retatrutide OR LY3437943 OR LY3502970 OR orforglipron OR Mazdutide OR LY3305677 OR IBI362 OR semaglutide OR CagriSema OR Amycretin OR XW004 OR XW014 OR XW010 OR XW003 OR XW013 OR XW015 OR AMG133
Get the latest updates from ClinicalTrials.gov: Tirzepatide OR Mounjaro OR LY3298176 OR Retatrutide OR LY3437943 OR LY3502970 OR orforglipron OR Mazdutide OR LY3305677 OR IBI362 OR semaglutide OR CagriSema OR Amycretin OR XW004 OR XW014 OR XW010 OR XW003 OR XW013 OR XW015 OR AMG133 directly as they happen.
Follow now < 10 followers
Latest posts
Last updated about 23 hours ago
A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)
1 day ago
Conditions: Obesity; Weight Gain Interventions: Drug: Tirzepatide; Drug: Placebo Sponsors: Eli Lilly...
A Study to Evaluate the Effect of Retatrutide on Insulin Secretion and Insulin Sensitivity in Adult Participants With Type 2 Diabetes Mellitus
1 day ago
Conditions: Diabetes Mellitus; Insulin Sensitivity Interventions: Drug: Retatrutide; Drug: Semaglutide; Drug: Placebo...
Tirzepatide in Idiopathic Intracranial Hypertension Trial
1 day ago
Conditions: Idiopathic Intracranial Hypertension (IIH) Interventions: Drug: Tirzepatide; Drug: Tirzepatide Placebo Sponsors...
A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes
1 day ago
Conditions: Obesity; Overweight; Type 2 Diabetes Interventions: Drug: Orforglipron; Drug: Placebo Sponsors...
Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)
1 day ago
Conditions: Type 2 Diabetes Interventions: Drug: Retatrutide; Drug: Placebo Sponsors: Eli Lilly...
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
1 day ago
Conditions: Obesity; Overweight Interventions: Drug: Orforglipron; Drug: Placebo Sponsors: Eli Lilly and...
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)
1 day ago
Conditions: Atherosclerotic Cardiovascular Disease (ASCVD); Chronic Kidney Disease (CKD) Interventions: Drug: Retatrutide...
SELECT-LIFE: A Research Study Looking at Long-term Effects of Semaglutide in People Who Took Part in the SELECT Cardiovascular Outcomes Trial
1 day ago
Conditions: Overweight; Obesity Interventions: Other: No treatment given Sponsors: Novo Nordisk A/S...
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain
1 day ago
Conditions: Obesity; Overweight; Chronic Low Back Pain (CLBP) Interventions: Drug: Retatrutide; Drug...
Tirzepatide in MetALD
1 day ago
Conditions: Metabolic Alcohol-associated Liver Disease; Alcohol Use Disorder Interventions: Drug: Tirzepatide; Other...
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in the United Kingdom, as Part of Local Clinical Practice
3 days ago
Conditions: Diabetes Mellitus, Type 2 Interventions: Drug: Oral semaglutide Sponsors: Novo Nordisk...
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Sweden, as Part of Local Clinical Practice
3 days ago
Conditions: Diabetes Mellitus, Type 2 Interventions: Drug: Oral Semaglutide Sponsors: Novo Nordisk...